Thyrocare Technologies Ltd THYROCARE-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 03/04/21 IST
919.00UNCH (UNCH)
52 week range
409.60 - 1,212.00

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close919.00
  • 52 Week High1,212.00
  • 52 Week High Date10/27/20
  • 52 Week Low409.60
  • 52 Week Low Date03/13/20
  • Market Cap650.06M
  • Shares Out52.83M
  • 10 Day Average Volume195,876.91
  • Dividend12.50
  • Dividend Yield1.36%
  • Beta
  • 1 Year % Change56.03

RATIOS/PROFITABILITY

  • EPS (TTM)14.02
  • P/E (TTM)65.56
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date11/12/2020
  • Div Amount10.00
  • Split Date-
  • Split Factor-

Latest Thyrocare Technologies Ltd News

There is no recent news for this security.

Latest THYROCARE-IN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Thyrocare Technologies Limited is an India-based healthcare service provider. The Company operates with a centralized processing laboratory (CPL) in Mumbai, India for esoteric tests, and regional processing laboratory in metro cities of India and other parts of Asia. The Company offers technologies, including Chemiluminescence Immunoassay (CLIA), Enzyme Linked Immunosorbent Assay (ELISA), High Performance Liquid Chromatography (HPLC), Capillary Electrophoresis (CE), Ion...
Amruta Velumani
Chairman
Arindam Haldar
Chief Executive Officer
A. Sundararaju
Chief Financial Officer
Ramjee Dorai
General Counsel
Address
D-37/1, Midc, Turbhe, Opp., Sandoz
Navi Mumbai
400703
India